Glenn Harvey
Illustrator
From this contributor
How long-read sequencing will transform neuroscience
New technology that delivers much more than a simple DNA sequence could have a major impact on brain research, enabling researchers to study transcript diversity, imprinting and more.
How long-read sequencing will transform neuroscience
What kind of autism research should we do, and where should we do it?
Researchers at INSAR 2023 need to discuss these questions and remember that the purpose of research may be different for different communities.
What kind of autism research should we do, and where should we do it?
New measure characterizes gender diversity in study participants
The Gender Self-Report could help autism researchers include more gender-diverse people across a range of ages and neurotypes in their work.
New measure characterizes gender diversity in study participants
Lessons from n-of-1 trials: A conversation with Joseph Gleeson
Some conditions are too rare for conventional drug trials, leading some scientists to test bespoke treatments in single participants. Gleeson discusses the merits — and limitations — of these tiny trials.
Lessons from n-of-1 trials: A conversation with Joseph Gleeson
Debut drug for Rett syndrome at edge of approval
The U.S. Food and Drug Administration plans to make an approval decision on the first-ever drug for girls and women with Rett syndrome by 12 March.
Debut drug for Rett syndrome at edge of approval
Explore more from The Transmitter
Up and out with Peggy Mason
Mason helped define the rodent prosocial behavior field, but now she’s changing course.
Up and out with Peggy Mason
Mason helped define the rodent prosocial behavior field, but now she’s changing course.
The spectrum goes multidimensional in search of autism subtypes
Grouping people with autism based on shared features, genetics and co-occurring conditions may improve clinical trial outcomes, researchers say.
The spectrum goes multidimensional in search of autism subtypes
Grouping people with autism based on shared features, genetics and co-occurring conditions may improve clinical trial outcomes, researchers say.
Exclusive: Harvard University lays off fly database team
The layoffs jeopardize this resource, which has served more than 4,000 labs for about three decades.
Exclusive: Harvard University lays off fly database team
The layoffs jeopardize this resource, which has served more than 4,000 labs for about three decades.